Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > DehydraTECH THC pouches to be sold in California

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon Sep 02, 2021 12:58pm

59 Views

Post# 33801161

RE:RE:DehydraTECH THC pouches to be sold in California

yay

company has 2 million in total sales last year (its loseing10s of millions)

so part of 2 milion has "dehyrdratech"

and they pay a royalty on that

for lexx it means

NOTHING!!!!!!!!!!!!!

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market